Abstract

Abstract This article provides a discussion of the use of computed tomography (CT) and magnetic resonance (MR) imaging in the preoperative evaluation of intraabdominal metastatic disease from colorectal cancer. Many technologic advances, including the development of MR contrast agents, have significantly improved these modalities' ability to detect, characterize, and evaluate the extent of metastatic disease. State of the art helical CT and MR imaging with contrast agents have essentially replaced CT arterial portography in most practices. Continued advances in CT and MR along with use of positron emission tomography with 2–[ 18 F] fluoro–2–deoxy–D–glucose (FDG–PET) will continue to improve the accuracy of preoperative imaging for colorectal cancer patients. Copyright © 2002 by W.B. Saunders Company

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.